Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: a multinational randomised, placebo-controlled, double-blind trial - the GAND-emesis study

Christina H. B. Ruhlmann, T B Christensen, L H Dohn, M Paludan, E Rønnengart, F Hilbert, P Feyer, G Kristensen, D Keefe, Olfred Hansen, Jørn Herrstedt

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2015
Publication statusPublished - 2015
EventEuropean Cancer Congress (ECC) 2015 - Wien, Austria
Duration: 25. Sep 201529. Sep 2015


ConferenceEuropean Cancer Congress (ECC) 2015

Cite this